Warren Buffett Smiles Bright On Completion Of Cancer Treatments

  on
Warren Buffett Completes Cancer Treatment
File photo of Warren Buffett touring the trade show floor during the Berkshire Hathaway Annual shareholders meeting in Omaha

There is some good news cheering up Warren Buffet, the Oracle of Omaha, as he announced completion of cancer treatments, Sept.14.

Speaking to executives representing newspapers he acquired in recent months, Berkshire Hathaway CEO said: "It's a great day for me. Today, I had my 44th and last day of radiation," Berkshire-owned Omaha World-Herald reported.

Earlier, in April 2012, Buffett, 82, revealed that he was diagnosed with Stage 1 prostate cancer and noted that it "is not remotely life-threatening or even debilitating in any meaningful way."

"If you're 81, and you have stage one prostate cancer, it's not going to be the thing that kills you in all probability. And you engage in radiation, which even reduces it further," Buffett told Bloomberg

Buffett who celebrated his birthday Aug.30, distributed more of his $44 billion fortune on the occasion to his three children, for their charitable foundations, the Associated Press (AP) reported.

In February 2012, Berkshire stated it has identified the manager who would step in as CEO if necessary, and that there were two back-up candidates.

Apparently, the billionaire has said his son, Howard Buffett, a farmer and Berkshire director, would help maintain the company's identity as non-executive chairman. Berkshire has hired two former hedge fund managers Todd Combs and Ted Weschler in the past two years to help oversee investments, Bloomberg pointed out. 

According to the American Joint Committee on Cancer, stage 1 prostate cancer does not cause symptoms. It is estimated that half of 90-year-old men have it.

Expressing relief on completion of radiation treatments, Buffett said: "I'll be feeling the side effects for a few weeks yet, but I am so glad to say that's over."

The Berkshire Hathaway scrip (NYSE: BRK-A) closed Sept.14, at $133,000, up $149 posting 0.11 percent gain over the previous close.

Join the Discussion